Regeneron Pharmaceuticals Inc. sell robertinio
Start price
20.04.20
/
50%
€534.90
Target price
01.05.20
-
Performance (%)
-9.33%
End price
01.05.20
€485.00
Summary
This prediction ended on 01.05.20 with a price of €485.00. With a performance of -9.33%, the SELL prediction by robertinio was trending in the right direction. robertinio has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 1.632% | 1.632% | 24.736% | -7.866% |
| iShares Core DAX® | -1,11 % | 0,20 % | 1,21 % | 51,83 % |
| iShares Nasdaq 100 | -4,35 % | -3,25 % | 25,87 % | 80,64 % |
| iShares Nikkei 225® | -6,79 % | -7,72 % | 50,97 % | 69,24 % |
| iShares S&P 500 | -1,79 % | 0,99 % | 21,07 % | 67,42 % |
Comments by robertinio for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Sell Regeneron Pharmaceuticals Inc.